Seong; Seung Kyoo

Patent Applications and Registrations

Patent applications and USPTO patent grants for Seong; Seung Kyoo.The latest application filed is for "complex formulation comprising hmg-coa reductase inhibitor and clopidogrel".

Company Profile

2.7.13

Seong; Seung Kyoo - Incheon KR
Seong; Seung Kyoo - Gyeonggi-do KR
SEONG; Seung Kyoo - Yeonsu-gu KR
SEONG; Seung Kyoo - Dongchun-3dong KR
Seong; Seung-Kyoo - Kyunggi-do KR

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Composition containing extract or fraction of genus Justicia plant Grant 10,688,143 - Yoon , et al.	2020-06-23
Complex Formulation Comprising Hmg-coa Reductase Inhibitor And Clopidogrel App 20200129440 - Baek; Nam Hyun ; et al.	2020-04-30
Composition Containing Extract Or Fraction Of Genus Justicia Plant App 20170360862 - Yoon; Joo Byoung ; et al.	2017-12-21
R-7-(3-aminomethyl-4-methoxyimino-3-methyl-pyrrolidin-1-yl)-1-cyclopropyl-- 6-fluoro-4-oxo-acid and L-aspartic acid salt, process for the preparation thereof and pharmaceutical composition comprising the same for antimicrobial Grant 9,751,840 - Choi , et al. September 5, 2	2017-09-05
R-7-(3-aminomethyl-4-methoxyimino-3-methyl-pyrrolidin-1-yl)-1-cyclopropyl-- 6-fluoro-4-oxo-1,4-dihydro-[1,8]naphthyridine-3-carboxylic Acid And L-aspartic Acid Salt, Process For The Preparation Thereof And Pharmaceutical Composition Comprising The Same For Antimicrobial App 20160362377 - CHOI; Dong Rack ; et al.	2016-12-15
R-7-(3-aminomethyl-4-methoxyimino-3-methyl-pyrrolidin-1-yl)-1-cyclopropyl-- 6-fluoro-4-oxo-1 acid and L-aspartic acid salt, process for the preparation thereof and pharmaceutical composition comprising the same for antimicrobial Grant 9,452,158 - Choi , et al. September 27, 2	2016-09-27
R-7-(3-aminomethyl-4-methoxyimino-3-methyl-pyrrolidin-1-yl)-1-cyclopropyl-- 6-fluoro-4-oxo-1,4-dihydro-[1,8]naphthyridine-3-carboxylic Acid And L-aspartic Acid Salt, Process For The Preparation Thereof And Pharmaceutical Composition Comprising The Same For Antimicrobial App 20150374674 - CHOI; Dong Rack ; et al.	2015-12-31
R-7-(3-aminomethyl-4-methoxyimino-3-methyl-pyrrolidin-1-yl)-1-cyclopropyl-- 6-fluoro-4-oxo-1 acid and L-aspartic acid salt, process for the preparation thereof and pharmaceutical composition comprising the same for antimicrobial Grant 9,150,576 - Choi , et al. October 6, 2	2015-10-06
R-7-(3-aminomethyl-4-methoxyimino-3-methyl-pyrrolidin-1-yl)-1-cyclopropyl-- 6-fluoro-4-oxo-1,4-dihydro-[1,8]naphthyridine-3-carboxylic Acid And L-aspartic Acid Salt, Process For The Preparation Thereof And Pharmaceutical Composition Comprising The Same For Antimicrobial App 20150105558 - CHOI; Dong Rack ; et al.	2015-04-16
R-7-(3-aminomethy-4-methoxyimino-3-methyl-pyrrolidin-1-yl)-1-cyclopropyl-6- -fluoro-4-oxo-1,4-dihydo-[1,8]naphthyridine-3-carboxylic acid and l-aspartic acid salt, process for the preparation thereof and pharmaceutical composition comprising the same for antimicrobial Grant 8,952,164 - Choi , et al. February 10, 2	2015-02-10
R-7-(3-aminomethyl-4-methoxyimino-3-methyl-pyrrolidin-1-yl)-1-cyclopropyl-- 6-fluoro-4-oxo-1,4-dihydro-[1,8]naphthyridine-3-carboxylic Acid And L-aspartic Acid Salt, Process For The Preparation Thereof And Pharmaceutical Composition Comprising The Same For Antimicrobial App 20140128610 - CHOI; Dong Rack ; et al.	2014-05-08
R-7-(3-aminomethyl-4-methoxyimino-3-methyl-pyrrolidin-1-yl)-1-cyclopropyl-- 6-fluoro-4-oxo-1,4-dihydro-[1,8]naphthyridine-3-carboxylic acid and L-aspartic acid salt, process for the preparation thereof and pharmaceutical composition comprising the same for antimicrobial Grant 8,664,240 - Choi , et al. March 4, 2	2014-03-04
R-7-(3-aminomethyl-4-methoxyimino-3-methyl-pyrrolidin-1-yl)-1-cyclopropyl-- 6-fluoro-4-oxo-1,4-dihydro-[1,8]naphthyridine-3-carboxylic Acid And L-aspartic Acid Salt, Process For The Preparation Thereof And Pharmaceutical Composition Comprising The Same For Antimicrobial App 20120130075 - Choi; Dong Rack ; et al.	2012-05-24
Novel Imatinib Camsylate And Method For Preparing Thereof App 20100317853 - Oh; Yoon Seok ; et al.	2010-12-16
N-hydroxy-4- {5- [4- (5-isopropyl-2-methyl-1, 3-thiazol-4-yl) phenoxy] pentoxy} benzamidine 2 methanesulfonic acid salt App 20090176846 - Ryu; Jei Man ; et al.	2009-07-09
Radionuclide-Chitosan Complex Having an Improved Stablilized Gelatin in Administering Them to the Body and Their Preparation Method App 20080166297 - Ryu; Jei-Man ; et al.	2008-07-10
Method For Preparing Radioactive Film App 20080031811 - Ryu; Jei-Man ; et al.	2008-02-07
Oral Preparation Having Improved Bioavailability App 20070254930 - Ryu; Jei Man ; et al.	2007-11-01
A radiosotope-chitosan complex for treatment of prostate cancer App 20060286032 - Ryu; Jei-Man ; et al.	2006-12-21

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.